FDA fully approves Leqembi, first drug to slow progression of Alzheimer's disease

Name: FDA fully approves Leqembi, first drug to slow progression of Alzheimer's disease
Uploaded: 2023-07-07T08:02:00-0400
Duration: 5 min 48 s
Description: The FDA has approved a drug for people in the early stages of Alzheimer's disease. CBS News' chief medical correspondent Dr. Jon LaPook explains how it works, the risks and who might benefit.

The FDA has approved a drug for people in the early stages of Alzheimer's disease. CBS News' chief medical correspondent Dr. Jon LaPook explains how it works, the risks and who might benefit.